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Brief communicationHigh fat diet causes rebound weight gainDavid E.G. McNay 1, John R. Speakman 1,2,*ABSTRACTObesity is at epidemic proportions but treatment options remain limited. Treatment of obesity by calorie restriction (CR) despite having initial
success often fails due to rebound weight gain. One possibility is that this reflects an increased body weight (BW) set-point. Indeed, high fat diets
(HFD) reduce adult neurogenesis altering hypothalamic neuroarchitecture. However, it is uncertain if these changes are associated with weight
rebound or if long-term weight management is associated with reversing this.
Here we show that obese mice have an increased BW set-point and lowering this set-point is associated with rescuing hypothalamic
remodelling. Treating obesity by CR using HFD causes weight loss, but not rescued remodelling resulting in rebound weight gain. However, treating
obesity by CR using non-HFD causes weight loss, rescued remodelling and attenuates rebound weight gain. We propose that these phenomena
may explain why successful short-term weight loss improves obesity in some people but not in others.
& 2013 Published by Elsevier GmbH.
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Obesity is at epidemic proportions in many developed nations, but
treatment options remain limited. The homoeostatic body weight (BW)
set-point theory is strongly supported by the counter-measures that are
enabled to resist weight loss under calorie restriction (CR) [1], and the
subsequent return to their original body weight after dieting is
terminated, called rebound weight gain [2]. However, such robust
homoeostatic regulation is difficult to reconcile with environmental
influences on BW; feeding mice a high fat diet (HFD) induces obesity
(DIO) which can be reversed by feeding regular chow [3]. One proposed
solution to this paradox is that the BW set-point is altered by
environmental factors via changes in the neuroarchitecture of the
homoeostatic energy balance circuit [4] and indeed, the properties of
homoeostatic energy balance are altered by HFD and restored by
feeding regular chow [3]. Recently, remodelling of the hypothalamus
has been identified in obese mice and humans [5] and we have
discovered that dietary regulation of hypothalamic neurogenesis alters
hypothalamic neuroarchitecture [6].
Treatment of obesity by reducing calorie intake, despite having a good
success rate in promoting initial weight-loss, has a generally poor
outcome for long-term weight control [7]. Indeed the large scale
Diabetes Prevention Program [8] and its follow up the Look Ahead trial
[9] demonstrate that the short-term success of lifestyle change in
lowering obesity is offset in the long-term by rebound weight gain. The
mechanisms underlying long-term rebound weight gain remain unclear
although the homoeostatic BW set-point theory suggests that obese
subjects have a higher BW set-point reflecting an underlying defect of
the homoeostatic energy balance circuit. Those individuals who achieve
long-term weight management after caloric restriction (CR) may have
successfully lowered their set-point while rebound weight gain mayhttp://dx.doi.org/10.1016/j.molmet.2012.10.003
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restriction. However, it is uncertain if obese individuals do have an
increased BW set-point and if successful long-term weight manage-
ment is associated with reversing this.
Here we follow up on our recent study of dietary regulation of
proliferative remodelling in the murine hypothalamus [6] and find that
obese mice do have an increased BW set-point and that lowering this
set-point is associated with rescuing proliferative remodelling. We
show that hypothalamic remodelling and long-term BW control are
distinct from short-term BW changes, and propose that these
phenomena may explain why successful short-term weight loss
improves obesity in some people but not in others.2. RESULTS AND DISCUSSION
2.1. Both calorie restriction and HFD reduce hypothalamic proliferative
remodelling
The hypothalamic energy balance circuit is remodelled by ongoing adult
neurogenesis; in lean mice old neurons are replaced by newborn
neurons [6]. However, neurogenesis is reduced in both diet induced obesity
(DIO) and genetic obesity; in obese mice newborn neurons are not
generated and old neurons are retained [6]. This change is not permanent,
and inducing weight loss in DIO animals by CR rescues proliferative
remodelling in the hypothalamic niche [6]. However, it is unclear if this
rescue is complete, and the extent to which macronutrient composition of
diet during CR affects the extent of rescue. To test the extent of
proliferative remodelling during weight loss and the role of dietary
macronutrients in this process, we fed 6 week old mice HFD for 10
weeks to induce obesity. We then treated these 16 week old DIO mice with
diets rich in a single macronutrient high protein (HPD), high carbohydrateState Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy
rdeen AB39 2PN, UK. Tel.: þ44 1224272879; Fax: þ44 1224272396.
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Diet %Energy Fat %Energy
Protein
%Energy
Carbohydrate
Gross energy
(kJ/g)
Manufacturer Reference
HFD 45 20 35 20.1 Research Diets D12451
HCD 10 20 70 16.3 Research Diets D12450B
HPD 13.2 42.6 44.3 15.9 Teklad TD90018
KD 93.4 4.7 1.8 30.1 Bio-Serv F3666
Chow 9.1 22.0 68.9 13.8 Special diets
services
801722
Table 1: Composition of the diets used (data as provided by manufacturer).
Figure 1: Calorie restriction of obese mice using HFD fails to rescue hypothalamic proliferative remodelling. 16 week old
obese mice were treated using 4 diets for 4 weeks, either ad-lib (AL) or at 70% of normal daily calorie intake of lean controls
(CR). (a) Treatment of obese mice caused significant BW loss in all groups except mice fed HFD AL. (b) Treating obese mice
by CR resulted in identical final BW irrespective of macronutrient composition, while AL treatment resulted in differential final
BW dependent on macronutrient composition. (c) Although CR with HFD lowered BW, it did not rescue hypothalamic
proliferative remodelling. Non-HFD diets rescued proliferative remodelling irrespective of dietary macronutrient composition
under both CR and AL. However, CR inhibited the rescue of proliferative remodelling compared to AL treatment (po0.001).
CR also reduced proliferative remodelling in lean controls. The rescue of hypothalamic proliferative remodelling during
treatment of obesity was incomplete in all groups and did not reach the level seen in control mice not previously exposed to
HFD. (*po0.05, graphs show box plots, N¼7 mice per group).
Brief communication(HCD), ketogenic (KD¼high fat and low protein and carbohydrate)
or maintained them on HFD for 4 weeks (see Table 1 for diet details).
Diet treated mice where further sub-divided by feeding either ad-lib
(AL) or CR at 30% of daily energy intake with a final group size of
7 mice per diet/feeding regime combination. The extent of proliferative
remodelling in the arcuate nucleus (ARC)/median eminence (ME)
niche was measured by BrdU incorporation during the last week of
treatment (Figure 1).
As expected DIO mice maintained on ad-lib HFD did not lose weight
while DIO mice treated with HFD-CR lost weight (Figure 1a). Treatment
of DIO mice with non-HFD diets either ad-lib or under CR also caused
weight loss (Figure 1a). When fed ad-lib, macronutrient composition
had a significant effect on final BW (po0.001), but had no effect on
final BW under CR (Figure 1b). For all diets, CR of DIO mice resulted in
a final BW similar to chow fed controls treated with CR (Figure 1b).
DIO mice fed HFD with 45% of energy derived from fat (Table 1) had a
significantly reduced proliferative remodelling compared to chow fed
controls (Figure 1c). This is in agreement with our previous finding in
mice fed HFD with 58% of energy derived from fat [6] suggesting that
reduced proliferative remodelling is a general feature of mice fed HFDs.
Treating DIO mice with ad-lib HPD, HCD and KD led to a significant
recovery of proliferative remodelling, although this recovery did not
reach the level seen in ad-lib controls (Figure 1c). Likewise, treating
DIO mice with HPD, HCD and KD under CR led to a significant recovery
of proliferative remodelling (Figure 1c). This recovery of proliferative
remodelling under CR was significantly less than seen in ad-lib fed
mice (po0.001). The finding that CR inhibits proliferative remodelling
compared to ad-lib feeding was confirmed in chow fed controls;
CR significantly inhibited hypothalamic proliferative remodelling in
non-obese mice (Figure 1c).
While CR had a significant inhibitory effect on recovery of proliferative
remodelling there was no compounding effect of individual dietary
macronutrients (p¼0.865, HCD, HPD and KD). However, DIO mice fed
HFD-CR showed no recovery of proliferative remodelling despite weight
loss, indicating a significant (po0.001) and specific effect of HFD on
the rescue of proliferative remodelling (Figure 1c).
To further investigate the effect of CR and HFD on proliferative
remodelling, alongside ad-lib fed DIO and control mice we pair-fed
mice HCD or HFD from 6 to 20 weeks of age, with hypothalamic
remodelling measured by BrdU incorporation at 20 weeks as above.
Each pair-fed mouse was fed a single daily meal containing the age
matched energy intake of ad-lib fed controls (Control AL in Figure 1)
i.e. 0%CR (Supplementary Figure 1). This experiment revealed that HFD
consumption under pair-feeding (0%CR) did not result in either weight
gain or weight loss while hypothalamic proliferative remodelling was
reduced to the level seen in both HFD ad-lib fed DIO mice and DIO mice
treated with HFD 30%CR. This data confirms that this pattern of
proliferative remodelling reflects HFD consumption and not current BW.
Remarkably, HCD pair-fed mice (0%CR) had a similar final BW to
HCD ad-lib controls but the moderately reduced level proliferative104 MOLECULAR METABOLISM 2 (2013) 103–108 & 2remodelling seen in control mice treated with HCD 30%CR
(Supplementary Figure 1). These data suggest that the moderate
reduction in hypothalamic proliferative remodelling seen in CR treated013 Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-ND license.
mice is not due to reduced energy intake but a response to the feeding
regime (i.e. a single daily meal during the day).
2.2. Both overweight and underweight mice show reduced
hypothalamic proliferative remodelling
This complex regulation of hypothalamic proliferative remodelling
excludes a linear relationship between BW and hypothalamic remodel-
ling i.e. ad-lib HFD fed mice and HFD-CR treated mice have identical
levels of hypothalamic proliferative remodelling despite the former
being obese while the later underweight. Moreover, chow fed controls
and HPD-AL treated DIO mice have similar BWs but different levels of
proliferative remodelling (compare Figure 1a and b).
The relationship between body weight and proliferative remodelling
was determined by regression across all previously obese mice which
showed no linear relationship (p¼0.478) but a second order poly-
nomial relationship (po0.001) with hypothalamic proliferative remo-
delling highest in normal weight mice and lower in both overweight and
underweight mice (Figure 2). We [6] and others [11] have recently
suggested that obesity is associated with a loss of new neurons in the
adult hypothalamus while others have argued that obesity is associated
with increased new neurons in the adult hypothalamus [10]. However,
the finding that reduced proliferation is associated with both overweight
and underweight mice strongly suggests that neither position is correct
and that the relationship between BW and hypothalamic remodelling is
qualitative rather than quantitative.
This discovery of a non-linear relationship supports a complex
mechanism underlying the role of hypothalamic proliferative remodel-
ling in regulation of BW i.e. a lower rate of hypothalamic remodelling is
not always associated with obesity. Rather the data suggests that
changes in hypothalamic proliferative remodelling reflect adaptive
remodelling of the energy balance circuit in response to diet which
in turn leads to an altered BW set-point i.e. HFD induced proliferative
remodelling alters hypothalamic neuroarchitecture increasing the BW
set-point in obesity [6]. This view is supported by the finding that
blocking hypothalamic proliferative remodelling by irradiation prior to
exposure to HFD attenuates weight gain [10] i.e. proliferative
remodelling is required for weight gain; while IKKb-mediated inhibition
of hypothalamic neurogenesis induces obesity [11]. The discovery that
reducing hypothalamic neurogenesis both prevents and causes obesity
supports the view that the relationship between BW and hypothalamicFigure 2: Both overweight and underweight mice show reduced hypothalamic proliferative remodelling. 16 week old obese
mice were treated using 4 diets for 4 weeks, either ad-lib (AL) or at 70% of normal daily calorie intake (CR). Regression
analysis of hypothalamic proliferative remodelling and BW across all mice showed no linear relationship (p¼0.478) but a
second order polynomial relationship (po0.001) with hypothalamic proliferative remodelling highest in normal weight mice
and lower in both overweight and underweight mice.
MOLECULAR METABOLISM 2 (2013) 103–108 & 2013 Published by Elsevier GmbH. Open access underremodelling is qualitative, with BW determined by the delicate balance
between orexigenic and anorexigenic neurons mediated by subtle
alteration of neuroarchitecture. This is supported by our finding that
subtle alteration of the energy balance circuit neuroarchitecture by
transplantation of small numbers of neurons results in long-term BW
change [12].
2.3. HFD raises the BW set-point and prevents successful treatment of
obesity by calorie restriction
As ad-lib HFD alters hypothalamic proliferative remodelling [6],
a process which is required for weight gain in DIO [10], and DIO mice
subsequently fed the same HFD under CR retain this pattern despite
weight loss, we next directly measured the BW set-point in mice
exposed to HFD. As before mice were fed HFD from 6 weeks of age for
10 weeks to induce obesity. At 16 weeks of age, DIO was treated by
feeding mice the 4 diets (HCD, HPD, KD and HFD) for 4 weeks under CR
with a final group size of 5–6 mice. At 20 weeks of age mice were
released from CR onto ad-lib chow with rebound BW and post-release
hyperphagia measured (Figure 3).
CR successfully induced weight loss in all DIO mice with all mice
reaching a similar BW and adiposity to CR treated controls (Figure 3aFigure 3: Treatment of obesity by calorie restriction using HFD results in long-term rebound weight gain. 16 week old obese
mice were treated using 4 diets for 4 weeks at 70% of normal daily calorie intake and released onto ad-lib chow at 20
weeks. (a) All mice treated by CR lost BW. At the point of release from CR onto ad-lib chow the BW of all groups was similar
and not affected by CR diet macronutrient composition or previous obesity. Obese mice treated with HFD-CR rebounded to a
higher BW compared to controls and obese mice treated with CR using non-HFD diets indicating an increased BW set-point.
Although there was a trend for obese mice treated with non-HFD diets to have a higher BW than control mice this only
reached statistical significance at a single time point in the case of HCD. (b) All CR treated mice displayed post-restriction
hyperphagia compared to control mice fed chow ad-lib. The increase in rebound BW in obese mice treated with HFD-CR was
not due to increased post-restriction hyperphagia in these mice. Likewise, while post-restriction hyperphagia was reduced in
obese mice treated with KD-CR this did not result in reduced rebound BW in KD-CR treated mice. (*po0.05, graphs show
box plots, N¼5–6 mice per group).
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Brief communicationand data not shown). Hence, when released from CR mice differed only
in previous macronutrient exposure and not BW, adiposity or current
diet. We predicted that DIO animals treated with HFD-CR would
rebound to a higher BW than those on the other 3 diets, who would
in turn rebound higher than mice that were placed under CR but had
not previously been DIO.
As expected, all mice showed significant rebound weight gain after
release from CR (Figure 3a, po0.001). However, rebound BW was
significantly different across treatment groups with obese mice treated
with HFD-CR rebounding to a higher BW than controls (Figure 3a).
Although DIO mice treated with non-HFD showed a trend towards
higher rebound BW than controls, this only reached statistical
significance at a one point in the case of HCD (Figure 3a). Hence the
failure to achieve long-term weight control following CR only occurred
in obese mice fed HFD during CR, coinciding with the maintenance of
altered hypothalamic remodelling.
The increase in rebound BW in DIO mice treated with HFD-CR was not
permanent but resolved after 6 weeks of ad-lib chow re-feeding. Given the
similarly in macronutrient content between chow and HCD (see Table 1)
this may reflect the loss of the altered HFD pattern of hypothalamic
remodelling due to consumption of a high carbohydrate, low fat diet.
This increase in BW long-term in HFD-CR treated mice was not due to
an acute increase in post-CR hyperphagia; HFD-CR treated DIO mice
did not show increased hyperphagia compared to CR treated controls
(Figure 3b). However, macronutrient composition during CR did have an
effect on post-release hyperphagia. Mice treated with KD-CR had
significantly reduced post-CR hyperphagia compared to both controls
and DIO mice treated with other diets (Figure 3b). However, this did not
result in decreased rebound weight gain (Figure 3a).
2.4. The success of treating obesity in the short-term does not predict
long-term success
Together these and previous data [4,6,7,10] suggest that alteration of
hypothalamic neuroarchitecture via proliferative remodelling alters theFigure 4: Short-term efficacy of obesity treatment by CR does not predict long-term efficacy. Individual variation in BW, adiposity
either individually or together. This indicates that the success of obesity treatment measured at the end of treatment does not
106 MOLECULAR METABOLISM 2 (2013) 103–108 & 2BW set-point and this mediates the long-term success of obesity
treatment. This suggests that measuring the efficacy of obesity
treatment immediately following CR will not predict long-term success.
To test this, we analysed the predictive power of BW and adiposity
(%body fat) at the end of CR treatment of obesity as well as post-CR
hyperphagia (24 h food intake, 3rd day after release from CR) in
predicting long-term BW (BW 4 weeks after release from CR) in the CR
treated DIO mice as a single group (Figure 4).
Neither BW nor adiposity at the end of CR predicted long-term BW.
Likewise, individual hyperphagic response following release from CR
did not predict long-term BW. Taken together the acute success of
obesity treatment as measured by BW, adiposity and food intake at the
end of CR treatment predicted none of the variation in BW one month
after cessation of treatment (Figure 4 and data not shown). These data
support the view that treating obesity with CR does not by itself cure
obesity despite treating the overt symptom of increased BW. Rather
both the amount of calories consumed during restriction and the
macronutrient composition of the diet are both important factors
influencing successful long-term BW control.
While these data confirm that HFD increases the BW set-point such that
following weight loss DIO mice rebound to a higher BW than lean controls,
and supports a role for proliferative remodelling of the hypothalamic
energy balance circuit in this process, the precise mechanism by which
proliferative remodelling causes altered hypothalamic function remains
unclear. Although our data focuses on overall rate of proliferative
remodelling suggesting that the ratio of new to older neurons may be
important, alteration of the balance between NPY to POMC neuronal
populations or the alteration of neuronal subtypes within NPY and POMC
populations may also play a role in altered hypothalamic function.
It is of particular interest that the specific effect of moderately high fat
diet (HFD) to alter hypothalamic proliferative remodelling is not shared
by ultra high fat ketogenic diet (KD). While this could be due to the
difference in the source of dietary fat, in both diets fat is predominantly
of animal origin (lard and/or butterfat). This may point to a specificand hyperphagic response (releaseþ3 days) following cessation of CR treatment of obesity do not predict BW 4 weeks later
predict the long-term efficacy in preventing rebound weight gain.
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requirement for the presence of both fat and carbohydrate in the diet,
although a protective effect of ketosis masking the effect of dietary fat
in the case of KD cannot be excluded. Likewise, while both HCD and
HFD share a 1:1 sucrose to starch ratio, HFD which is lower in sucrose
(17% by energy content) reduces hypothalamic remodelling and causes
rebound weight gain while HCD which is higher in sucrose (35% by
energy content) does not. Together these data suggest that hypotha-
lamic remodelling is regulated complex mechanisms involving response
to multiple dietary macronutrients.
While the mechanism by which HFD specifically alters hypothalamic
remodelling remains unclear, the discovery that the IKKb/NF-kB pathway
regulates hypothalamic neurogensis [11] and identification of inflammatory
changes in the hypothalamus of obese mice and humans [5] suggests that
local inflammatory processes may play a critical role. This central role for
proliferative remodelling of hypothalamic neurocircuitry in response to HFD
does not preclude roles for other mechanisms in mediating homoeostatic
plasticity in a variable environment.
Overall a growing pool of evidence supports the view that changes in
the BW set-point in response to environmental signals is a critical
factor in the pathogenesis of obesity and provides a model for
integrating the considerable physiological evidence for a BW set-
point with the equally considerable evidence for environmental causes
underlying the obesity epidemic [4]. Our results provide a mechanistic
framework for understanding how environmental factors such as
macronutrient composition of diet can be integrated into the homoeo-
static hypothalamus leading to long-term changes in the BW set-point,
providing a bridge between internal homoeostatic control of body
weight and the external environmental driven obesity epidemic. We
confirm that short-term weight loss does not cure obesity, and describe
a mechanistic process apparently underlying the failure of some
individuals to achieve long-term weight loss despite successful
short-term weight loss. Manipulation of hypothalamic remodelling
provides an attractive and novel target in the quest for a successful
long-term cure of obese individuals with refractory obesity.3. METHODS
3.1. Mice
Male C57BL/6 mice were obtained from the Charles River Laboratories at
4 weeks of age. Animals were housed under a 12/12 light/dark cycle. Mice
were maintained at an ambient temperature of 21 1C with a relative
humidity of 55710%. Mice were group housed 3 per wire-top cage until
16 weeks of age and then singly housed. Food intake was determined by
weighing food remaining in the hopper. All procedures were authorised by
the College of Life Sciences and Medicine Ethics Review Board at the
University of Aberdeen and by the UK Home office (PPL 60/3706).
3.2. Dietary manipulations
Mice were obtained from the Charles River Laboratories at 4 weeks of age
and fed and chow (SDS Nutrition) from 4 to 6 weeks of age ad-lib.
At 6 weeks of age DIO mice were fed HFD to induce obesity, while lean
control mice were fed HCD diet. For details of diets see Table 1. At 16
weeks of age DIO mice were fed one of the four test diets either ad-lib or at
70% of the daily energy intake of lean control mice as a single daily pellet
(30%CR). Likewise, at 16 weeks of age lean control mice were either
maintained on HCD ad-lib (Control AL) or fed HCD at 70% of the daily energy
intake of lean control mice as a single daily pellet (Control CR). Control daily
food intake was the daily average between 8 and 16 weeks for all control
mice (subsequently Control AL and Control CR in Figure 1) and was used forMOLECULAR METABOLISM 2 (2013) 103–108 & 2013 Published by Elsevier GmbH. Open access undeall experiments (daily average¼49.15 kJ/day, 30%CR¼34.41 kJ/day). For
re-feeding experiments mice were fed chow ad-lib from 20 weeks of age.
For pair-feeding experiments mice were fed either HCD or HFD at 100% of
the daily energy intake of lean control mice as a single daily pellet, from
6 weeks to 20 weeks of age. Control daily food intake was the daily average
for all control mice (subsequently Control AL and Control CR in Figure 1) and
was matched for week 6 (daily average¼39.86 kJ/day), week 7 (daily
average¼45.38 kJ/day), and then the daily average between 8 and 16
weeks was used subsequently (daily average¼49.15 kJ/day).
3.3. Body composition
Body composition was determined by calibrated [13] dual energy X-ray
absorptometry (PIXImus2) at 15 weeks and 20 weeks of age.
3.4. BrdU labelling
In brief (see [6]), mice under ketamine and xylazine anaesthesia
(45 mg/kg and 5 mg/kg) were implanted with a subcutaneous osmotic
minipump (2001, 1 ml/h, 7days, Alzet) at 19 weeks of age. Each
minipump was filled with bromodeoxyuridine (BrdU, Sigma) in saline
20 mg/ml. 7 days later (at the end of BrdU infusion without a chase
period) mice were killed by cardiac perfusion with 10% formalin.
3.5. Histology and cell counting
Following cardiac perfusion, brains were removed and post-fixed for
24 h in 10% formalin before cryoprotection in 30% sucrose (wt/vol).
Brains were then embedded in OCT compound (CellPath), stored at
80 1C and cut into 12 mM coronal sections using a cryostat (10
series/brain). The total number of BrdU labelled cells in 3 central
hypothalamic sections containing the ARC were counted manually.
3.6. Immunohistochemistry
Slides were treated with 2 N HCl for 2 h followed by 6 washing with
PBS before incubation in primary BrdU antibody (1:200,Abcam) diluted
in PBSþ0.1%TritonX100þ1%BSA overnight at 4 1C. Sections were
washed 3 with PBSþ0.1%TritonX100 before incubation in second-
ary Cy3-anti-rat antibody (1:400,Abcam) diluted in PBSþ0.1%Tri-
tonX100þ1%BSA for 2 h at room temperature. Sections were
washed 3 with PBSþ0.1%TritonX100 before imaging.
3.7. Imaging
Stained sections were examined using an Axiovert 200M microscope
(Zeiss). Images were processed using Photoshop 7.0 (Adobe). Figures
were prepared using Prism 5 (Graphpad).3.8. Statistical analysis
Statistical analysis was carried out using Minitab 16 (Minitab). Z-tests
were used to determine significance of weight loss. One way or two
way ANOVA was used to determined differences between treatment
groups followed by post-hoc Tukey’s comparisons to identify specific
differences. Regression analysis was used to determine the relationship
between variables. po0.05 was considered significant.ACKNOWLEDGEMENTS
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